Hong Kong stock turnover weakened

April 15 News, investors continue to stay on the sidelines on the eve of the mainland's first-quarter economic data, with Hong Kong stocks trading at less than 130 a day, with turnover falling to a two-week low.　　However, the price stocks have been hyped, and some fine-priced stocks and gem shares have risen by 20% to one-fold. According to media reports in Hong Kong, investors continued to stay on the sidelines on the eve of the first quarter's economic data, resulting in a very cowhide-covered Hong Kong stock, less than 130 a day, and a drop in turnover to a two-week low of about $58 billion.　　The index closed at 22,121 points, up only 17 points.　　Fine price Create plate stocks the most strength of more than times although the city since the rise through 22,000 points has been a breakthrough weakness, however, the speculation on individual three or four-line shares has never been interrupted, and yesterday the funds were flowing to the fine-priced stocks, with many fine-priced stocks and gem shares rising by 20% to more than one-fold. The market is looking at the number of economic data released today, including the first-quarter GDP growth and the fact that the inflation figures are of the highest concern, which will have implications for the time when the authorities start raising interest rates in the future.　　At present, the first quarter GDP growth in the mainland is expected to be 11.7% and the consumer price index (CPI) is 2.6%. Institutional Investor brokers say that in the absence of a clear direction in the big city, funds moved to fine stock yesterday, but the concept of a lot of shareholders have taken advantage of the high priority in the first batch of stocks out of the field, reflecting the short term of the big city on the space has been limited, or to be the first consolidation, to the end of this month, the first quarter of the announcement of the　　However, fund managers also said that as the central government was determined to drop heavy drugs on property, the strong inflation figures announced today would deter investors from the recent increase in the number of BOC shares. After a number of new shares have been approved by shareholders, the recent speculation in the pharmaceutical stocks yesterday also is a wave. Huahan biopharmaceutical (0587) to the old after the new way, discount 12%, that is, 2.67 of the placing price, wholesale 264.74 million shares, fund-raising up to 707 million yuan.　　Another Chinese Medicine dividend June International (2005) yesterday also suspended, said to announce the issue of rights issues to raise funds. Huahan pharmaceutical stocks up to more than 700 million gem shares rose alarmingly, the Great Wall Glimmer (8286) and the Chinese data Broadcast (8016) and so on, and rose more than 10% of the fine price stocks are everywhere.　　In Friday, the Italian Horse International (0585) has continued to be hyped, over the past 3 days has risen more than 3 times times, yesterday Rose 50%, close to 0.242 yuan, turnover of up to 2.9 billion shares, the transaction amount of more than 600 million yuan, accounted for the big city sold to 1%, the hype of the enthusiasm of the market to amaze the people.　　Some brokers remind investors that, based on past experience, many fine-priced stocks may fall sharply after the start of equity trading. ING released the first-quarter investor sentiment index, which fell slightly from 147 in the last quarter to 145 points in the first quarter of this year but remained upbeat, with Hong Kong rising from 144 in the last quarter to 148 to return to the pre-crisis highs. INGLiang Jianhui, senior investment manager for Investment Management Asia-Pacific, said inflation is now one of the investors ' concerns, and that inflation-resistant investments can take into account the renminbi, which is a low-risk investment option when the renminbi is expected to rise by about a 3至5% this year. With the recovery in Europe and the US, and increased demand for retail goods, Liang expects export stocks, energy and shipping stocks to outperform the market this season.